We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Bertilsson, L., Mellctrom, B. & Sjoqvist, F. (1979) Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptyline. Life Sciences, 25,1285–1292.Google Scholar
Young, R. C., Alexopoulos, G. S., Shamoian, C. A. & Kutt, H. (1984) Heart failure associated with high plasma 10-hydroxynor-triptylinc levels. American Journal of Psychiatry, 141,432–433.Google ScholarPubMed
Young, R. C., Alexopoulos, G. S., Shamoian, C. A. & Kutt, H. (1984) Plasma 10-hydroxynortriptyline in elderly depressed patients. Clinical Pharmacology and Therapeutics, 35, 540–544.CrossRefGoogle ScholarPubMed
Young, R. C., Alexopoulos, G. S., Shamoian, C. A. & Kutt, H. (1985) Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients. American Journal of Psychiatry, 142, 866–868.Google Scholar
eLetters
No eLetters have been published for this article.